Frequency of EGFR Mutations in Greek Non-Small-Cell Lung Cancer (NSCLC) Patients

被引：0
|
作者：
Nasioulas, G. [1 ]
Efstathiadou, C. [1 ]
Murray, S. [1 ]
Dahabreh, I. [2 ]
机构：
[1] GENEKOR, Glyka Nera, Greece
[2] Tufts Med Ctr Boston, Inst Clin Res & Hlth Policy Studies, Amarousion Athens, Greece
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72450-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S635 / S635
页数：1
相关论文
共 50 条
  • [41] Phase I/II study of ASP8273 in patients with non-small-cell lung cancer (NSCLC) harboring EGFR activating mutations
    Shimizu, Toshio
    Nokihara, Hiroshi
    Murakami, Haruyasu
    Seto, Takashi
    Nishio, Makoto
    Takeda, Koji
    Inoue, Akira
    Kiura, Katsuyuki
    Azuma, Koichi
    Keating, Anne
    Krivoshik, Andrew
    Uegaki, Koichi
    Takeda, Kentaro
    Komatsu, Kanji
    Morita, Satoshi
    Fukuoka, Masahiro
    Nakagawa, Kazuhiko
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 82 - 82
  • [42] Non-small-cell lung cancer (NSCLC) tumors from gefitinib-responsive patients (pts) harbor EGFR kinase domain mutations
    Rosell, Rafael
    Ichinose, Yukito
    Taron, Miquel
    Sarries, Carme
    Queralt, Cristina
    Ono, Mayumi
    Manegold, Christian
    Mok, Tony
    Miguel Sanchez, Jose
    Massuti, Bartomeu
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 166 - 166
  • [43] Novel EGFR mutations in patients with non small cell lung cancer (NSCLC) and correlation T with sensitivity to gefitinib
    Voutsina, A.
    Koutsopoulos, A.
    Kalykaki, A.
    Souglakos, I.
    Pallis, A.
    Trypaki, M.
    Mavroudis, D.
    Georgoulias, V.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 250 - 251
  • [44] Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
    O'Leary, Connor
    Gasper, Harry
    Sahin, Katherine B.
    Tang, Ming
    Kulasinghe, Arutha
    Adams, Mark N.
    Richard, Derek J.
    O'Byrne, Ken J.
    [J]. PHARMACEUTICALS, 2020, 13 (10) : 1 - 16
  • [45] Spectrum of germline mutations in smokers and non-smokers in Brazilian non-small-cell lung cancer (NSCLC) patients
    Couto, Patricia P.
    Bastos-Rodrigues, Luciana
    Schayek, Hagit
    Melo, Flavia M.
    Lisboa, Raony G. C.
    Miranda, Debora M.
    Vilhena, Alyne
    Bale, Allen E.
    Friedman, Eitan
    De Marco, Luiz
    [J]. CARCINOGENESIS, 2017, 38 (11) : 1112 - 1118
  • [46] Acquired EGFR-resistant mutations in non-small cell lung cancer (NSCLC).
    Raez, Luis E.
    Baca, Yasmine
    Nieva, Jorge J.
    Mamdani, Hirva
    Lopes, Gilberto
    Borghaei, Hossein
    Socinski, Mark A.
    Nabhan, Chadi
    Wozniak, Antoinette J.
    Vanderwalde, Ari M.
    Uribe, Carlos Carracedo
    Khan, Hina
    Liu, Stephen V.
    Nagasaka, Misako
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] A REVIEW OF ETOPOSIDE IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER (NSCLC)
    ITRI, LM
    GRALLA, RJ
    [J]. CANCER TREATMENT REVIEWS, 1982, 9 : 115 - 118
  • [48] Therapy of non-small-cell lung cancer (NSCLC) in patients with HIV infection
    Spina, M
    Sandri, S
    Serraino, D
    Gobitti, C
    Fasan, M
    Sinicco, A
    Garavelli, PL
    Ridolfo, A
    Tirelli, U
    [J]. ANNALS OF ONCOLOGY, 1999, 10 : 87 - 90
  • [49] Surgical outcomes in elderly non-small-cell lung cancer (NSCLC) patients
    Skrzypski, M
    Dziadziuszko, R
    Kobierska-Gulida, G
    Rzyman, W
    Zurek, W
    Skokowski, J
    Jassem, E
    Jassem, J
    [J]. LUNG CANCER, 2004, 45 : S48 - S48
  • [50] BRAF Mutations in Non-Small-Cell Lung Cancer
    Smit, Egbert
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (11) : 1594 - 1595
12345